Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized Phase III Trial of Paclitaxel + Trastuzumab + Lapatinib Versus Paclitaxel + Trastuzumab as Neoadjuvant Treatment of HER2-Positive Primary Breast CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: CALGBStatus: Closed to Accrual. Pts Have Completed InterventionReview Status: Available to Open
